DRIVE-AB received significant attention at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2015 in Copenhagen, Denmark, this year. The congress ran from the 25th to 28th of April, and incorporated a series of lectures, symposium, educational workshops and meet-the-expert sessions which covered the entire field of infectious diseases and clinical microbiology.
DRIVE-AB was discussed in a presentation by Inge Gyssens, Work Package 1A academic leader, titled What is responsible use? View of low-resistance countries on Sunday, April 26. The project was also featured on a Center for Anti-Infective Agents (CEFAIA) poster at the Pipeline Corner titled “Antibacterial drug research and development. The poster describes the landscape of antibacterial R&D today, and how DRIVE-AB aims to find solutions to the barriers that face antibacterial innovation.
Ursula Theuretzbacher, Work Package 3B academic leader, was interviewed over the weekend about DRIVE-AB, and presented the DRIVE-AB poster at the European Network Corner.
Click to view a press release about Novel approaches to fight infections presented at the Pipeline Corner at ECCMID
Click to view a summary published by Medscape on the symposium, What is responsible antimicrobial use?, titled Antibiotic resistance powered by cultural norms
The posters from ECCMID can be viewed here:
European Network Corner poster (DRIVE-AB): Driving reinvestment in R&D for antibiotics and advocating their responsible use
Pipeline Corner poster (CEFAIA): Antibacterial drug research & development